Squarepoint Ops LLC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 196 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2020. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.

Quarter-by-quarter ownership
Squarepoint Ops LLC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q4 2022$166,896
-15.7%
13,492
-5.0%
0.00%0.0%
Q3 2022$198,000
-82.7%
14,200
-82.8%
0.00%
-83.3%
Q2 2022$1,143,000
+72.1%
82,749
+102.8%
0.01%
+100.0%
Q1 2022$664,000
-33.5%
40,808
-33.5%
0.00%0.0%
Q4 2021$999,000
-0.3%
61,328
-9.1%
0.00%0.0%
Q3 2021$1,002,000
+53.9%
67,504
+107.0%
0.00%
+50.0%
Q2 2021$651,000
-58.7%
32,616
-52.2%
0.00%
-77.8%
Q1 2021$1,576,000
+107.6%
68,302
+273.2%
0.01%
-10.0%
Q3 2020$759,000
+23.2%
18,300
+42.2%
0.01%0.0%
Q2 2020$616,000
-19.6%
12,867
+5.8%
0.01%
-50.0%
Q1 2020$766,000
-35.8%
12,164
-32.3%
0.02%
+81.8%
Q3 2019$1,193,000
+247.8%
17,979
+428.9%
0.01%
+175.0%
Q4 2018$343,000
-17.3%
3,399
+3.6%
0.00%
-20.0%
Q3 2018$415,000
-88.6%
3,281
-94.7%
0.01%
-92.2%
Q4 2017$3,648,000
-2.4%
62,445
+102.3%
0.06%
-13.5%
Q2 2017$3,737,000
+400.9%
30,865
+367.7%
0.07%
+252.4%
Q1 2017$746,000
+32.0%
6,600
+26.9%
0.02%
-8.7%
Q4 2016$565,000
+49.1%
5,200
+126.1%
0.02%
-8.0%
Q3 2016$379,000
+1.6%
2,300
-20.7%
0.02%
-13.8%
Q1 2016$373,0002,9000.03%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q1 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 640,688$9,514,0001.49%
CM Management, LLC 45,000$668,0000.50%
EULAV Asset Management 660,000$9,801,0000.26%
DLD Asset Management, LP 225,200$3,346,0000.24%
Virtus ETF Advisers LLC 21,387$318,0000.14%
GSA CAPITAL PARTNERS LLP 79,145$1,175,0000.12%
Hennion & Walsh Asset Management, Inc. 136,720$2,030,0000.11%
ALTRINSIC GLOBAL ADVISORS LLC 168,800$2,507,0000.08%
Inspire Investing, LLC 31,868$473,0000.06%
DUALITY ADVISERS, LP 51,196$760,0000.06%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders